Cargando…

Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease

MicroRNAs (miRs) are promising diagnostic, prognostic and therapeutic biomolecules for atherosclerotic cardiovascular disease. Atherosclerotic occlusive disease concerns a large population of patients, carrying the highest incidence of fatal and non-fatal adverse events, such as myocardial infarctio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabłak-Ziembicka, Anna, Badacz, Rafał, Przewłocki, Tadeusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698927/ https://www.ncbi.nlm.nih.gov/pubmed/36431326 http://dx.doi.org/10.3390/jcm11226849

Ejemplares similares

microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician’s Perspective
por: Badacz, Rafał, et al.
Publicado: (2022)

Cardiac microRNAs: diagnostic and therapeutic potential
por: Kabłak-Ziembicka, Anna, et al.
Publicado: (2023)

MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease
por: Badacz, Rafał, et al.
Publicado: (2022)

The Maintained Glycemic Target Goal and Renal Function Are Associated with Cardiovascular and Renal Outcomes in Diabetic Patients Following Stent-Supported Angioplasty for Renovascular Atherosclerotic Disease
por: Badacz, Rafał, et al.
Publicado: (2022)

Long-term outcomes and determinants of stenosis recurrence after renal artery angioplasty in hypertensive patients with renovascular disease
por: Rosławiecka, Agnieszka, et al.
Publicado: (2019)

Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events
por: Badacz, Rafał, et al.
Publicado: (2021)

Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events
por: Badacz, Rafal, et al.
Publicado: (2018)

Clinical Characteristics and Outcomes of Aortic Arch Emergencies: Takayasu Disease, Fibromuscular Dysplasia, and Aortic Arch Pathologies: A Retrospective Study and Review of the Literature
por: Wawak, Magdalena, et al.
Publicado: (2023)

Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients
por: Kabłak-Ziembicka, Anna, et al.
Publicado: (2021)

Magnetic resonance imaging and clinical outcome in patients with symptomatic carotid artery stenosis after carotid artery revascularization
por: Badacz, Rafał, et al.
Publicado: (2017)

The role of serial carotid intima-media thickness assessment as a surrogate marker of atherosclerosis control in patients with recent myocardial infarction
por: Gacoń, Jacek, et al.
Publicado: (2019)

Low prevalence of collateral cerebral circulation in the circle of Willis in patients with severe carotid artery stenosis and recent ischemic stroke
por: Badacz, Rafał, et al.
Publicado: (2015)

Multimarker Approach in Discriminating Patients with Symptomatic and Asymptomatic Atherosclerotic Carotid Artery Stenosis
por: Musialek, Piotr, et al.
Publicado: (2013)

Importance of Increased Arterial Resistance in Risk Prediction in Patients with Cardiovascular Risk Factors and Degenerative Aortic Stenosis
por: Baran, Jakub, et al.
Publicado: (2021)

Serum and Vascular Stiffness Biomarkers Associated with the Severity of Degenerative Aortic Valve Stenosis and Cardiovascular Outcomes
por: Baran, Jakub, et al.
Publicado: (2022)

Transcranial doppler ultrasonography should it be the first choice for persistent foramen ovale screening?
por: Komar, Monika, et al.
Publicado: (2014)

Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest
por: Podolec, Jakub, et al.
Publicado: (2019)

Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions
por: Musialek, Piotr, et al.
Publicado: (2012)

Association of Increased Vascular Stiffness with Cardiovascular Death and Heart Failure Episodes Following Intervention on Symptomatic Degenerative Aortic Stenosis
por: Baran, Jakub, et al.
Publicado: (2022)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Simultaneous vertebral and subclavian artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2017)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Severe, recurrent in-stent carotid restenosis: endovascular approach, risk factors. Results from a prospective academic registry of 2637 consecutive carotid artery stenting procedures (TARGET-CAS)
por: Tekieli, Łukasz, et al.
Publicado: (2019)

Increased risk profile in the treatment of patients with symptomatic degenerative aortic valve stenosis over the last 10 years
por: Baran, Jakub, et al.
Publicado: (2018)

Special Issue “The Prevention and Treatment of Atherosclerosis”
por: Kabłak-Ziembicka, Anna
Publicado: (2022)

Improving Cardiovascular Outcomes: The Era of Personalized Therapy in Atherosclerosis
por: Kabłak-Ziembicka, Anna
Publicado: (2022)

Altered Serum MicroRNAs as Novel Diagnostic Biomarkers for Atypical Coronary Artery Disease
por: Wang, Jun, et al.
Publicado: (2014)

Imaging modality-dependent carotid stenosis severity variations against intravascular ultrasound as a reference: Carotid Artery intravasculaR Ultrasound Study (CARUS)
por: Tekieli, Lukasz, et al.
Publicado: (2023)

Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Clinical applications of microRNAs
por: Hydbring, Per, et al.
Publicado: (2013)

Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease
por: Zhang, Lei, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers for severe coronary artery disease
por: Zhang, Xuelin, et al.
Publicado: (2020)

Circulating microRNAs in patients with aneurysmal dilatation of coronary arteries
por: Iwańczyk, Sylwia, et al.
Publicado: (2022)

MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease
por: Zhang, Yuan, et al.
Publicado: (2019)

MicroRNAs - Biology and clinical applications
por: Ranganathan, Kannan, et al.
Publicado: (2014)

Analysis of MicroRNAs Associated With Carotid Atherosclerotic Plaque Rupture With Thrombosis
por: Nie, Peng, et al.
Publicado: (2021)

Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion
por: Liu, Yan, et al.
Publicado: (2015)

MicroRNA expression profile of human advanced coronary atherosclerotic plaques
por: Parahuleva, Mariana S., et al.
Publicado: (2018)

Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs
por: Pankiewicz, Katarzyna, et al.
Publicado: (2021)

The Investigation of Serum Vaspin Level in Atherosclerotic Coronary Artery Disease
por: Kobat, Mehmet Ali, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fg5stfkgk14r7idb7739jkh0dd